Keymed Biosciences (2162.HK) Earnings Analysis
Keymed Biosciences (2162.HK) next reports earnings on 2026-09-01, consensus EPS 5.31 HKD. Last quarter (2026-03-26) it missed with EPS -1.78617 HKD vs -1.45787 HKD est (-22.5%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -41.87.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2162.HK next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | 5.31 HKD |
| Revenue estimate | 0.71B |
2162.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | -1.78617 HKD | -1.45787 HKD | -22.5% | Miss |
| 2025-06-30 | -0.32636 HKD | n/a | n/a | n/a |
| 2025-03-24 | -0.72381 HKD | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
2162.HK valuation and analyst view
| Trailing P/E | -41.87 |
|---|---|
| Trailing EPS | -1.72476 HKD |
| Price / book | 7.93 |
| Dividend yield | 0.00% |
| Market cap | 24.63B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Keymed Biosciences (2162.HK)'s next earnings date?
Keymed Biosciences is next scheduled to report on 2026-09-01, with a consensus EPS estimate of 5.31 HKD and revenue estimate of 0.71B.
Did 2162.HK beat earnings last quarter?
In its 2026-03-26 report, 2162.HK posted EPS of -1.78617 HKD versus a -1.45787 HKD estimate — a miss of 22.5%.
What is 2162.HK's earnings track record?
Over the last 1 reported quarters with consensus data, 2162.HK beat estimates 0 times (0%).
What is 2162.HK's current P/E ratio and EPS?
2162.HK trades at a trailing P/E of -41.87 on trailing EPS of -1.7247576674589093 HKD.
What do analysts rate 2162.HK?
2162.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.